Aarkstore.com || Post-Myocardial Infarction – Pipeline Review, H1 2012 || Market Research latest report

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Post-Myocardial Infarction – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Post-Myocardial Infarction - Pipeline Review, H1 2012,
provides an overview of the Post-Myocardial Infarction therapeutic pipeline. This
report provides information on the therapeutic development for Post-Myocardial
Infarction, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Post-Myocardial Infarction. Post-Myocardial Infarction - Pipeline
Review, H1 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Post-Myocardial Infarction.
- A review of the Post-Myocardial Infarction products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined

2. therapeutics.
Table of contents:
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Post-Myocardial Infarction Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Post-Myocardial Infarction 6
Post-Myocardial Infarction Therapeutics under Development by Companies 8
Post-Myocardial Infarction Therapeutics under Investigation by
Universities/Institutes 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Pre-Clinical Stage Products 11
Comparative Analysis 11
Post-Myocardial Infarction Therapeutics – Products under Development by
Companies 12
Post-Myocardial Infarction Therapeutics – Products under Investigation by
Universities/Institutes 13
Companies Involved in Post-Myocardial Infarction Therapeutics Development 14
miRagen Therapeutics, Inc. 14
Post-Myocardial Infarction – Therapeutics Assessment 15
Assessment by Monotherapy Products 15
Assessment by Molecule Type 16
Drug Profiles 18
Natrecor - Drug Profile 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
MGN-1374 - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19

3. Post-Myocardial Infarction Therapeutics – Drug Profile Updates 20
Post-Myocardial Infarction – Product Development Milestones 21
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Refractory Angina – Pipeline Review, H1 2012
Post-Myocardial Infarction – Pipeline Review, H1 2012
Proteinuria – Pipeline Review, H1 2012
Ocular Pain – Pipeline Review, H1 2012
Pediculosis (Head Lice Infestation) – Pipeline Review, H1 2012
Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012
Thyroid Gland Disorders – Pipeline Review, H1 2012

4. Tinea Corporis – Pipeline Review, H1 2012
Pulmonary Fibrosis – Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com